Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:51 PM
Ignite Modification Date:
2025-12-24 @ 4:51 PM
NCT ID:
NCT02678650
Eligibility Criteria:
Inclusion Criteria:
* age \>18 years
* written informed consent;
* scheduled procedures;
* planned isolated OPCABG(multiple bypass are allowed; planned combined intervention such as CABG plus valve surgery are not allowed);
* ejection fraction\> 50%;
* NYHA class Ⅱ\~Ⅲ;
* serum creatinine \<150μmol / l;
* preoperative platelet content \> 100 × 109 / l;
* preoperative hemoglobin\> 120 g / l
Exclusion Criteria:
* pregnancy;
* planned valve surgery or surgery on the aorta;
* left main coronary artery stenosis\> 75%;
* echocardiographic examination revealed moderate to severe mitral, tricuspid, or aortic regurgitation or stenosis;
* unstable or ongoing angina;
* recent (\< 1 month) or ongoing acute myocardial infarction;
* use of sulfonylurea, theophylline or allopurinol;
* previous unusual response to an anesthetic agent;
* inclusion in other randomised controlled studies in the previous 30 days; (10)any general anesthesia performed in the previous 30 days;
* emergency operation (not scheduled);
* kidney or liver transplant in medical history, liver cirrhosis (Child B or C);
* chronic respiratory disease (such as chronic obstructive pulmonary emphysema)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT02678650
Study Brief:
Protocol Section:
NCT02678650